Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA | 46,763 | reported | 25 Feb 2026 | tx 148+154,232−122,389 |
| Odyssey Therapeutics, Inc. | 27,393 | reported | 07 May 2026 | tx 1+27,393 |
| Verve Therapeutics, Inc. | 0 | reported | 25 Jul 2025 | tx 4+309,741−309,741 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2026 | GRANT_AWARD | Odyssey Therapeutics, Inc. | 27,393 | 0.00 USD | deriv |
| 25 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 260 | 486.35 USD | |
| 24 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 1,627 | 485.11 USD | |
| 18 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 368 | 473.68 USD | |
| 17 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 609 | 489.46 USD | |
| 17 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 2,294 | 483.75 USD | |
| 17 Feb 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 5,789 | 0.00 USD | |
| 13 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 3,804 | 487.76 USD | |
| 13 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 1,500 | 499.99 USD | |
| 10 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 2,140 | 468.41 USD | |
| 11 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 466 | 460.43 USD | |
| 22 Jan 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 3,883 | 0.00 USD | |
| 22 Jan 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 7,866 | 0.00 USD | |
| 07 Jan 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 4,500 | 474.99 USD | |
| 03 Dec 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 4,500 | 449.99 USD | |
| 25 Jul 2025 | OTHER | Verve Therapeutics, Inc. | 42,200 | — | deriv |
| 25 Jul 2025 | OTHER | Verve Therapeutics, Inc. | 267,541 | — | deriv |
| 05 Jun 2025 | GRANT_AWARD | Verve Therapeutics, Inc. | 42,200 | 0.00 USD | deriv |
| 10 Mar 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 3,242 | 499.99 USD | |
| 04 Mar 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 4,058 | 485.49 USD | |
| 26 Feb 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 4,962 | 479.61 USD | |
| 27 Feb 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 530 | 475.34 USD | |
| 24 Feb 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 3,310 | 483.28 USD | |
| 25 Feb 2025 | SALE | VERTEX PHARMACEUTICALS INC / MA | 354 | 480.95 USD | |
| 14 Feb 2025 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 2,293 | 463.46 USD |